7 days ago
ATRC
AnalystsWilliam PlovanicWilliam Plovanic's Stock Forecasts
AnalystsWilliam Plovanic
Analyst Ranking
Bottom 14%
#4575 out of 5277 analysts
Average Return
-0.3%
Win Rate
38%72 out of 191
Risk vs Reward
Poor
Good
William Plovanic's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Neuronetics IncSTIM | +422.33% | $0.74 | $3.86 | 2024-08-12 - 2025-08-12 | Strong Buy |
Transmedics Group IncTMDX | +243.26% | $22.17 | $76.10 | 2022-03-16 - 2023-03-16 | Strong Buy |
Irhythm Holdings IncIRTC | +139.28% | $72.69 | $173.93 | 2024-09-24 - 2025-09-24 | Strong Buy |
Bioventus IncBVS | +128.57% | $5.11 | $11.68 | 2023-12-06 - 2024-12-06 | Strong Buy |
Irhythm Holdings IncIRTC | +109.36% | $82.79 | $173.33 | 2024-12-08 - 2025-12-08 | Strong Buy |
William Plovanic Analyst Color
Get additional color on William Plovanic's coverage of popular stocks
12 days ago
DXCM
2 months ago
HTFL
5 months ago
TLSI
5 months ago
CBLL
6 months ago
PODD
6 months ago
HTFL
6 months ago
PODD
6 months ago
AORT
6 months ago
IRTC
7 months ago
ANGO
7 months ago
BSX
7 months ago
IRTC
7 months ago
AORT
7 months ago
PODD
8 months ago
HTFL
9 months ago
PODD
9 months ago
AORT
9 months ago
IRTC
10 months ago
ANGO
10 months ago
TMDX
a year ago
DXCM
a year ago
STIM
a year ago
DXCM
a year ago
ATRC
William Plovanic's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ceribell IncCBLL | 6 | Strong Buy | $25.00 | +49.25% | Maintains | 18 hours ago |
Insulet CorpPODD | 9 | Strong Buy | $249.00 | +57.25% | Maintains | 6 days ago |
Transmedics Group IncTMDX | 10 | Strong Buy | $124.00 | +93.96% | Maintains | 7 days ago |
Atricure IncATRC | 14 | Strong Buy | $55.00 | +106.07% | Maintains | 7 days ago |
Irhythm Holdings IncIRTC | 15 | Strong Buy | $180.00 | +52.14% | Maintains | 12 days ago |
Dexcom IncDXCM | 11 | Strong Buy | $100.00 | +63.56% | Maintains | 12 days ago |
Edwards Lifesciences CorpEW | 28 | Hold | $85.00 | +6.61% | Maintains | 19 days ago |
Boston Scientific CorpBSX | 16 | Strong Buy | $71.00 | +31.24% | Maintains | 20 days ago |
Cvrx IncCVRX | 11 | Strong Buy | $10.00 | +89.75% | Maintains | a month ago |
Neuronetics IncSTIM | 5 | Strong Buy | $3.00 | +136.22% | Maintains | 2 months ago |
Heartflow IncHTFL | 5 | Strong Buy | $43.00 | +46.16% | Maintains | 2 months ago |
Trisalus Life Sciences IncTLSI | 7 | Strong Buy | $7.00 | +53.51% | Maintains | 2 months ago |
Artivion IncAORT | 5 | Strong Buy | $48.00 | +107.79% | Maintains | 3 months ago |
Tandem Diabetes Care IncTNDM | 7 | Strong Buy | $35.00 | +138.26% | Maintains | 5 months ago |
Angiodynamics IncANGO | 8 | Strong Buy | $18.00 | +65.14% | Maintains | 7 months ago |
Globus Medical IncGMED | 4 | Strong Buy | $90.00 | +18.22% | Maintains | 10 months ago |
Zimmer Biomet Holdings IncZBH | 3 | Hold | $101.00 | N/A | Maintains | a year ago |
Nevro CorpNVRO | 12 | Hold | $5.85 | N/A | Maintains | a year ago |
Inari Medical IncNARI | 12 | Hold | $80.00 | N/A | Downgrades | a year ago |
Bioventus IncBVS | 4 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
Shockwave Medical IncSWAV | 6 | Hold | $335.00 | N/A | Downgrades | 2 years ago |
Penumbra IncPEN | 4 | Strong Buy | $284.00 | N/A | Reiterates | 2 years ago |
Alphatec Holdings IncATEC | 1 | Strong Buy | $25.00 | N/A | Maintains | 2 years ago |
Pulmonx CorpLUNG | 4 | Strong Buy | $12.00 | N/A | Maintains | 3 years ago |
Merit Medical Systems IncMMSI | 4 | Hold | $70.00 | N/A | Maintains | 3 years ago |
Staar Surgical CoSTAA | 5 | Hold | $48.00 | N/A | Downgrades | 3 years ago |
Y Mabs Therapeutics IncYMAB | 3 | Strong Buy | $22.00 | N/A | Maintains | 3 years ago |
Vapotherm IncVAPO | 2 | Hold | $40.00 | N/A | Downgrades | 4 years ago |
Acutus Medical IncAFIB | 4 | Hold | $3.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.